
    
      The purpose of the study is to assess the overall quality of life and measure the impact on
      women who have survived breast cancer for at least 1 year (12 months) and 2 years (24 months)
      after the end of primary treatment and to identify possible repercussions of breast cancer
      and its treatments associated with Quality of Life.
    
  